The great majority of patients with LPL exhibit distinctive clinical features that can be attributed either to tissue infiltration with malignant B cells or IgM-dependent changes in serum (hyperviscosity syndrome) and/or various tissue sites (immunoglobulin deposition disease, autoimmunity). The gene discussed is CD40LG; the disease is Autoimmunity.